KRX · KRX Health Care 207940
Samsung Biologics share price
207940 · Samsung Biologics
₩980,000 ▲ ₩14,965 · +1.55%
After hours · 22:26 local Jun 26, 2026 Prices delayed ≥15 min Sample data
Price chart
…
Key statistics
Market cap
₩69.58T
P/E (TTM)
65.0×
EPS (TTM)
₩15,077
Dividend yield
—
52-week range
₩856,159 – ₩997,651
Avg volume
206.5K
Beta
1.34
Prev close
₩965,035
About Samsung Biologics
AI-assisted summarySamsung Biologics (207940) is a company listed on KRX in the Health Care sector. This page summarises its share price, key statistics, dividends and fundamentals using delayed and sample data — figures may differ from official sources.
Dividend history
Samsung Biologics does not currently pay a regular dividend.
Financials
Annual figures, last 5 fiscal years.
| Date | Revenue | Net income | EPS (TTM) | P/E (TTM) |
|---|---|---|---|---|
| FY2024 | ₩46.05T | ₩4.64T | ₩10,554 | 76.2× |
| FY2023 | ₩42.01T | ₩8.49T | ₩12,046 | 80.5× |
| FY2022 | ₩34.75T | ₩6.67T | ₩13,387 | 76.4× |
| FY2021 | ₩28.61T | ₩2.71T | ₩14,633 | 68.8× |
| FY2020 | ₩24.84T | ₩2T | ₩15,729 | 52.7× |
Stock splits
No stock splits on record for Samsung Biologics.
Analyst forecast
12-month price target
₩1,176,839
Consensus rating
Strong buy
Implied upside
+20.09%
Based on 20 analysts
12-month
Aggregated analyst estimates (sample)
Related
Frequently asked questions
What is the current Samsung Biologics share price?
Samsung Biologics (207940) last traded at ₩980,000, as of Jun 26, 2026. Prices on bourva are delayed and shown for reference only.
Does Samsung Biologics pay a dividend?
Samsung Biologics does not currently pay a regular dividend.
What is Samsung Biologics's market capitalisation?
Samsung Biologics has an approximate market capitalisation of ₩69.58T.
What is Samsung Biologics's P/E ratio?
Samsung Biologics trades at a trailing P/E ratio of about 65.0.